51 – 60 of 740
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Immunomodulation therapy offers new molecular strategies to treat UTI
(
- Contribution to journal › Scientific review
-
Mark
Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1, -3 and -8 inhibitors
(
- Contribution to journal › Article
-
Mark
Comorbidities in hereditary angioedema—A population-based cohort study
(
- Contribution to journal › Article
-
Mark
Combined genetic deficiencies of the classical complement pathway are strongly associated with both systemic lupus erythematosus and primary Sjögren's syndrome
(
- Contribution to journal › Article
-
Mark
Endocrine disrupting chemicals and breast cancer : a systematic review of epidemiological studies
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Benzimidazole–galactosides bind selectively to the Galectin-8 N-Terminal domain : Structure-based design and optimisation
(
- Contribution to journal › Article
-
Mark
Heparin fragments induce cervical inflammation by recruiting immune cells through Toll-like receptor 4 in nonpregnant mice
(
- Contribution to journal › Article
-
Mark
Collateral effects of deletion of nlpD on rpoS and rpoS-dependent genes. Reply.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Synthesis and Biological Studies of O3-Aryl Galactosides as Galectin Inhibitors
(
- Contribution to journal › Article
-
Mark
A bacterial protease depletes c-MYC and increases survival in mouse models of bladder and colon cancer
(
- Contribution to journal › Article